Profit from Real Estate Crowdfunding for Passive Income ✌️【Flexible Work】✌️Achieve financial freedom with ₹500. Invest smart and earn fast! Profit from Real Estate Crowdfunding for Passive Income - High Profits Quick Results High-Paying Part-Time Jobs for Professionals

Profit from Real Estate Crowdfunding for Passive Income ✌️【Flexible Work】✌️Achieve financial freedom with ₹500. Invest smart and earn fast!Pharmaceutical giant Dr Reddy’s Laboratories (DRL) saw its shares surge 4.34% on Thursday in an otherwise sluggish market, reaching an intraday high of Rs 1,330.45 following an upgrade by Nomura.The Tokyo-based brokerage has upgraded the stock from ‘Neutral’ to ‘Buy’ with a revised target price of Rs 1,500, down from Rs 6,499, factoring in the 1:5 stock split on October 28.“We assess that risk-reward is favourable and thus upgrade the stock to Buy (from Neutral).

Profit from Real Estate Crowdfunding for Passive Income ✌️【Flexible Work】✌️₹500 to unlock the potential for massive monthly earnings. Join now!We reduce FY25/26F earnings by 13%/14% to factor in higher overhead costs.

Note that changes to our earnings estimates and target price are due to DRL’s 1:5 stock split,” said Saion Mukherjee and AmlanJyotiDas, research analysts at Nomura.They also said the relative underperformance of the stock suggests that concerns about the high contribution of generic cancer drug gRevlimid are already priced in.

“We think the Street is concerned about the higher contribution from gRevlimid, which could start declining in FY26F.

Further, the overheads have increased significantly in the recent past.

In the first half of FY25, R&D/SG&A were higher by 29%/27% year-on-year.”While the stock has underperformed theNifty PharmaIndex over the past five years, the upgrade reflects Nomura’s confidence in Dr Reddy’s ability to overcome near-term challenges and capitalise on future opportunities.

Profit from Real Estate Crowdfunding for Passive Income ✌️【Flexible Work】✌️Start with ₹500 and earn steady, high returns every month!The stock has risen only 13% over the past year, compared to the Nifty Pharma Index’s 36% growth.

Profit from Real Estate Crowdfunding for Passive Income ✌️【Flexible Work】✌️Invest ₹500 and let your wealth grow with our proven, secure strategies!The underperformance persists despite a 22.Profit from Real Estate Crowdfunding for Passive Income Online Part-Time Jobs: Work from Anywhere